Project Number 1R01AG034155-01 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for STUDY ON THALIDOMIDE AS BACE1 INHIBITOR IN ALZHIEMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator SHEN, YONG Principal Investigator First Name YONG Principal Investigator Last Name SHEN Awardee Organization BANNER SUN HEALTH RESEARCH INSTITUTE Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-062: Alzheimers Disease Pilot Clinical Trials (R01) FY Overall Cost $868,159 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Repository [AlzPED] Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of beta-Secretase in a Mouse Model of Alzheimer’s Disease Clinical Trial Thalidomide for Patients With Mild to Moderate Alzheimer's Disease
